Edition:
United Kingdom

Catabasis Pharmaceuticals Inc (CATB.OQ)

CATB.OQ on NASDAQ Stock Exchange Global Market

4.28USD
15 Feb 2019
Change (% chg)

$-0.15 (-3.39%)
Prev Close
$4.43
Open
$4.41
Day's High
$4.51
Day's Low
$4.07
Volume
181,611
Avg. Vol
27,834
52-wk High
$21.70
52-wk Low
$3.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -7.994
Jun '18 0.00 -19.796
Mar '18 0.00 -28.815
FY 2017 Dec '17 0.25 -23.658
Sep '17 0.25 -31.099
Jun '17 0.00 -31.996
Mar '17 0.00 -41.250
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Quarter Ending Jun-19 1 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-19 2 -0.90 -0.90 -0.90 -3.40
Quarter Ending Jun-19 2 -0.93 -0.90 -0.96 -4.00
Year Ending Dec-19 3 -3.78 -3.50 -4.30 -12.73
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.44 33.70
P/E High - Last 5 Yrs. -- 147.79 49.87
P/E Low - Last 5 Yrs. -- 47.97 24.25
Beta -- 1.08 0.90
Price to Sales (TTM) -- 49.51 6.29
Price to Book (MRQ) 2.60 10.14 5.26
Price to Tangible Book (MRQ) 2.60 13.78 6.77
Price to Cash Flow (TTM) -- 56.20 24.98
% Owned Institutions 37.97 3.74 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.85
Payout Ratio(TTM) -- 7.02 41.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.92 12.75
Sales (TTM) vs TTM 1 Yr. Ago -- 48.79 5.84
Sales - 5 Yr. Growth Rate -- 22.76 11.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 47.92 75.85 47.15
EPS (TTM) vs TTM 1 Yr. Ago 27.59 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.85
Capital Spending - 5 Yr. Growth Rate -- 9.07 15.20

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.25
Current Ratio (MRQ) 3.72 3.50 3.08
LT Debt to Equity (MRQ) 3.86 18.65 11.38
Total Debt to Equity (MRQ) 19.07 31.33 16.12
Interest Coverage (TTM) -41.02 -43.11 29.47

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.24 53.81
Gross Margin - 5 Yr. Avg. -- 60.48 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.45 12.86
Operating Margin (TTM) -- -184.67 6.20
Operating Margin - 5 Yr. Avg. -- -126.94 8.31
Pre-Tax Margin (TTM) -- -175.36 7.16
Pre-Tax Margin - 5 Yr. Avg. -- -132.73 8.61
Net Profit Margin (TTM) -- -182.07 3.29
Net Profit Margin - 5 Yr. Avg. -- -137.12 4.89
Effective Tax Rate (TTM) -- 22.48 22.91
Effective Tax Rate - 5 Yr. Avg. -- 15.51 23.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 7,654,354 842,397,297
Net Income/Employee (TTM) -843,342 562,076 99,842,671
Receivable Turnover (TTM) -- 6.23 5.71
Inventory Turnover (TTM) -- 1.89 3.47
Asset Turnover (TTM) 0.00 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.03 6.39 11.06
Return on Assets - 5 Yr. Avg. -- 5.47 12.20
Return on Investment (TTM) -107.14 8.92 14.45
Return on Investment - 5 Yr. Avg. -- 6.78 15.87
Return on Equity (TTM) -117.90 10.08 15.96
Return on Equity - 5 Yr. Avg. -- 8.32 17.00
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -4.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Catabasis Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 74.27 68.26 99 99
13 Week 87.22 78.10 99 95
26 Week 74.13 60.89 99 98
52 Week -54.23 -61.20 32 72
YTD -31.02 -39.43 42 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 21.37%
# of Holders: 25
Total Shares Held: 2,380,514
3 Mo. Net Change: -701,474
# New Positions: 5
# Closed Positions: 14
# Increased Positions: 6
# Reduced Positions: 23
# Net Buyers: -17
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.